IL-6 is a cytokine that can drive NF-κB-mediated TIM4 upregulation and consequent NSCLC cell metastatic progression [16], in addition to inducing the phosphorylation of BECN1 so as to modulate chemoresistance and autophagic activity [17]. Here, IL6 is linked to non-small cell lung carcinoma.